These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1116437)

  • 1. [Serum level and urinary excretion of 14C-thiamozol in patients with hyperthyroidism (author's transl)].
    Balzer J; Lahrtz HG; van Zwieten PA
    Dtsch Med Wochenschr; 1975 Mar; 100(11):548-52. PubMed ID: 1116437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum levels and kinetics of digoxin in patients with hyperthyroidism (author's transl)].
    Gaita F; Bocchiardo M; Brossa C; Molinatti GM; Rosettani E; Brusca A
    G Ital Cardiol; 1980; 10(7):836-42. PubMed ID: 7461331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Absorption and excretion of g-strophanthin after intravenous or sublingual administration (author's transl)].
    Erdle HP; Schultz KD; Wetzel E; Gross F
    Dtsch Med Wochenschr; 1979 Jul; 104(27):976-9. PubMed ID: 456272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Kinetics of cefotaxime in healthy subjects (author's transl)].
    Acar JF; Guibert J; Kitzis MD
    Nouv Presse Med; 1981 Feb; 10(8):559-63. PubMed ID: 6259593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics of digoxin in patients with manifest hyperthyroidism and after normalization of thyroid function.
    Bonelli J; Haydl H; Hruby K; Kaik G
    Int J Clin Pharmacol Biopharm; 1978 Jul; 16(7):302-6. PubMed ID: 669876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The disposition and metabolic fate of 14C-cibenzoline in man.
    Massarella JW; Loh AC; Williams TH; Szuna AJ; Sandor D; Bressler R; Leinweber FJ
    Drug Metab Dispos; 1986; 14(1):59-64. PubMed ID: 2868867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No enhanced elimination of propranolol in patients with hyperthyroidism.
    Ishizaki T; Masuno M; Tawara K
    Res Commun Chem Pathol Pharmacol; 1980 Sep; 29(3):473-85. PubMed ID: 7423023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of propranolol in healthy cats during euthyroid and hyperthyroid states.
    Jacobs G; Whittem T; Sams R; Calvert C; Ferguson D
    Am J Vet Res; 1997 Apr; 58(4):398-403. PubMed ID: 9099387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bioavailability and pharmacokinetics of 14C-cyproterone acetate after administration as a 50-mg tablet (author's transl)].
    Speck U; Jentsch D; Kühne G; Schulze PE; Wendt H
    Arzneimittelforschung; 1976; 26(9):1717-20. PubMed ID: 1036708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics of AR-L 115 BS in rhesus monkeys (author's transl)].
    Mierau J
    Arzneimittelforschung; 1981; 31(1a):221-5. PubMed ID: 7195226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human plasma pharmacokinetics and urinary excretion of thiotepa and its metabolites.
    Cohen BE; Egorin MJ; Kohlhepp EA; Aisner J; Gutierrez PL
    Cancer Treat Rep; 1986 Jul; 70(7):859-64. PubMed ID: 2424593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aspects of bile acid metabolism in liver diseases(author's transl)].
    Horak W
    Acta Med Austriaca Suppl; 1975; 4():1-38. PubMed ID: 1064281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The Half-life of Endogenous Serum Immunoreactive Thyrotropin in Normal Subjects (author's transl)].
    Konno N
    Hokkaido Igaku Zasshi; 1974 Jan; 49(1):42-5. PubMed ID: 4218200
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on metabolism and pharmacokinetics of alpha-acetyldigitoxin in man (author's transl)].
    Bodem G; Wirth K; Dengler HJ
    Arzneimittelforschung; 1975 Sep; 25(9):1448-52. PubMed ID: 1242671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and clinical effects of atenolol in therapy of hyperthyroidism.
    Geffner DL; Sladek J; Hershman JM
    Drugs Exp Clin Res; 1990; 16(4):167-73. PubMed ID: 2076652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.